Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

TARAF

Financiado

Taxonomy and azole resistance in Aspergillus section Flavi

The project on taxonomy and azole resistance in Aspergillus section Flavi aims to investigate the classification and drug resistance patterns of fungal species within this specific section. Aspergillus section Flavi comprises vari... ver más

30/09/2026

KNAW

188K€

Presupuesto del proyecto: 188K€

Líder del proyecto

KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCH... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-08

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023

I+D

Cerrada hace 1 año

0% 100% 100%

1 Participantes

KNAW

187.62K€ | Lider

Proyectos interesantes

SAF2008-04143 DETECCION Y ESTUDIO DE LOS MECANISMOS DE RESISTENCIA A LOS A... 54K€ Cerrado

PID2020-117983RB-I00 NUEVOS ENFOQUES ANTIFUNGICOS: EVALUACION DE LA RELACION ENTR... 132K€ Cerrado

MycoViralPath The role of fungal viruses in shaping fungal pathogenesis an... 2M€ Cerrado

PDC2022-133266-I00 NUEVOS COMPUESTOS ANTIFUNGICOS CONTRA CANDIDA MULTIRESISTENT... 150K€ Cerrado

BFU2010-22172 REGULACION DE LA ADQUISICION DE ZINC POR ASPERGILLUS FUMIGAT... 121K€ Cerrado

PCI2022-135066-2 DISRUPTING DRUG RESISTANCE BY EXPLOITING COLLATERAL SENSITIV... 214K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 29 meses Fecha Inicio: 2024-04-08
Fecha Fin: 2026-09-30

Presupuesto del proyecto 188K€

Descripción del proyecto The project on taxonomy and azole resistance in Aspergillus section Flavi aims to investigate the classification and drug resistance patterns of fungal species within this specific section. Aspergillus section Flavi comprises various species known to produce carcinogenic aflatoxins, posing significant risks to human and animal health. The project involves taxonomic studies to accurately identify and classify different species within Aspergillus section Flavi. This classification is essential for understanding the diversity and distribution of these fungi, as well as their specific traits and potential virulence factors. Another crucial aspect of the project is the investigation of azole resistance in Aspergillus section Flavi. Azoles are commonly used antifungal drugs for treating Aspergillus infections. However, reports of azole resistance in certain Aspergillus species have raised concerns. Understanding the mechanisms behind azole resistance is crucial for developing effective treatment strategies and identifying potential targets for drug development. The project involves molecular analysis techniques to detect and characterize genetic mutations or other mechanisms associated with azole resistance in Aspergillus section Flavi. Additionally, it may involve assessing the clinical impact of azole resistance on patient outcomes and exploring potential risk factors for the development and spread of resistant strains. By combining taxonomic studies with investigations into azole resistance, the project aims to enhance our understanding of the diversity, distribution, and drug resistance profiles of Aspergillus species within section Flavi. This knowledge can ultimately contribute to improved diagnostic methods, treatment approaches, and public health strategies to mitigate the impact of these fungal infections.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores